Cann Group logo

Cann Group(ASX) CAN

Market CapA$9.96MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-99%
5 Year-98%
1 Year-57%
1 Month+20%
A$0.01
+0.00%
+0.00Today
Cann Group last closing stock price
MetricPriceDate
Last closeAUD 0.012026-10-09
Cann Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+50%AUD 0.002026-10-02
1 month+20%AUD 0.012026-09-09
3 month+50%AUD 0.002026-07-10
Year to date-33.33%AUD 0.012025-12-31
1 year-57.14%AUD 0.012025-10-09
3 year-95.2%AUD 0.132023-10-10
5 year-97.93%AUD 0.292021-10-08
Since inception-99.01%AUD 0.612017-05-04

Cann Group Financials at a Glance

Market Cap

A$9.96MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$21.82M

Net Income (TTM)

-A$2.04M

EPS (TTM)

A$0.03

P/E Ratio

0.21

Dividend

A$0.00

Beta (Volatility)

-0.16 (Low)

Price

A$0.01

Volume

336,470

Open

A$0.01

Previous Close

A$0.01

Daily Range

A$0.01 - A$0.01

52-Week Range

A$0.00 - A$0.02

Estimated Earnings Date

Feb 26, 2027

CAN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cann Group

Cann Group Limited, established in Port Melbourne, Australia, in 2014, specializes in the comprehensive lifecycle of medicinal cannabis. This includes genetic development, cultivation, manufacturing, clinical assessment, and the distribution of therapeutic cannabis products. The company supplies these products for use within Australia and also exports them to international markets, operating under specific licenses that permit research and the cultivation of cannabis for human medicinal and scientific purposes.

Products and Services
  • Genetic development of cannabis strains for medicinal use
  • Cultivation and manufacturing of therapeutic cannabis products
  • Distribution of products for both domestic and international markets
Growth Outlook
  • Expansion into international markets is underway, increasing revenue potential
  • Recent partnerships aim to enhance product offerings and market reach
  • Focus on R&D to innovate and improve product efficacy and safety
Financial Highlights
  • Recent quarterly revenue of AUD 4.04 million shows potential for growth
  • Trailing twelve months (TTM) revenue of AUD 24.5 million indicates a solid market presence
  • Net income for the latest quarter was a loss of AUD 6.08 million, reflecting ongoing investment in growth
Cann Group Limited is positioned in the rapidly growing medicinal cannabis sector, with a focus on innovation and market expansion. The company has made significant strides in developing its product line and establishing a presence in both domestic and international markets. Recent financial data indicates a commitment to growth, despite current losses, as the company invests in research and development to enhance its offerings. The potential for future profitability remains strong, driven by increasing demand for medicinal cannabis products.
AI Generated • Oct 1, 2026

Industry

Pharmaceuticals

CEO

Jennifer Lee Pilcher

Headquarters

Mildura, VIC 3501, AU

CAN Financials

Key Financial Metrics (TTM)

Gross Margin

-94.13%

Operating Margin

-131.65%

Net Income Margin

237.11%

Return on Equity

64.70%

Return on Capital

-26.44%

Return on Assets

39.05%

Earnings Yield

4.76%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$9.96MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.66B

Volume

336.47K

Avg. Volume

3.67M

Financials (TTM)

Gross Profit

-A$11.79M

Operating Income

-A$23.98M

EBITDA

-A$14.36M

Operating Cash Flow

-A$10.97M

Capital Expenditure

-A$563.00K

Free Cash Flow

-A$11.54M

Cash & ST Invst.

A$490.00K

Total Debt

A$16.84M

Cann Group Performance Analysis

Cann Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 13,777,000114.9%
20242024-06-30AUD 15,373,00011.6%
20252025-06-30AUD 11,300,000-26.5%
20262026-06-30AUD 8,563,000-24.2%
Cann Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31-28.5%
Q42025-06-304.9%
Q22025-12-31-33.4%
Q42026-06-30-10.6%
Cann Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD -0.0915.9%
20242024-06-30AUD -0.1131.4%
20252025-06-30AUD -0.04-62.5%
20262026-06-30AUD 0.01N/A
Cann Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-3173.5%
Q42025-06-309.4%
Q22025-12-31255.9%
Q42026-06-30-147.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$4.04M

-55.3%

Gross Profit

-A$3.60M

-291.8%

Gross Margin

-89.09%

N/A

Market Cap

A$9.96MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$249.09K

N/A

Employees

40

N/A

Net Income

-A$6.08M

+83.5%

EBITDA

-A$2.92M

+45.5%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$490.00K

-70.1%

Total Debt

A$16.84M

-76.8%

Accounts Receivable

A$1.14M

-72.1%

Inventory

A$5.40M

-47.0%

Long Term Debt

A$15.81M

+3655.3%

Short Term Debt

A$1.03M

-98.6%

Return on Assets

39.05%

N/A

Return on Invested Capital

-25.24%

N/A

Free Cash Flow

-A$1.62M

+82.6%

Operating Cash Flow

-A$1.32M

+85.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ICR.AXIntelicare Holdings Limited
A$0.02-12.50%
ECS.AXECS Botanics Holdings Ltd
A$0.01+0.00%
VBS.AXVectus Biosystems Limited
A$0.11+0.00%
HIQ.AXHITIQ Limited
A$0.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$33.79+10.24%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$142.52-10.31%
SPCXSpace Exploration Technologies
$160.57-4.20%
NOKNokia
$10.14-4.52%

Questions About CAN

What is the current price of Cann Group?

Cann Group is trading at A$0.01 per share.

What is the 52-week range for Cann Group?

Over the past 52 weeks, Cann Group has traded between A$0.00 and A$0.02.

How much debt does Cann Group have?

As of the most recent reporting period, Cann Group reported total debt of A$16.58M.

How much cash does Cann Group have on hand?

Cann Group reported A$490.00K in cash and cash equivalents in its most recent financial results.

What is Cann Group’s dividend yield?

Cann Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.